Best Practice e-Journal Home

Best Practice e-Journal - Issue 2

Welcome to Issue 2 of Best Practice Journal (eBPJ). In this edition we take a closer look at the two new medicines funded for people with type 2 diabetes, empagliflozin and dulaglutide. We update the evidence on lipid-lowering treatment, remind about best practice management of impetigo and as part of our ongoing series on cancer care in New Zealand, we focus on the detection and diagnosis of lung cancer. Also included in this edition are continuing professional development activities and a sneak peek at upcoming articles.